ENZO BIOCHEM. INC
ENZO BIOCHEM. INC
Acción · US2941001024 · ENZ · 865607 (XNYS)
Resumen Indicadores financieros
Sin cotización
n/a

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
- - 0,00 % -36,05 % -68,82 % -72,59 % -85,87 %

Perfil de la empresa para ENZO BIOCHEM. INC Acción

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.

Datos de la empresa

Nombre ENZO BIOCHEM. INC
Empresa Enzo Biochem, Inc.
Símbolo ENZ
Sitio web https://www.enzo.com
Mercado principal XNYS NYSE
WKN 865607
ISIN US2941001024
Tipo de valor Acción
Sector Healthcare
Industria Medical - Diagnostics & Research
CEO Ms. Kara Cannon
Capitalización de mercado 20 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 527 Madison Avenue, 10022 New York
Fecha de OPV 1980-06-12
Dividendos de 'ENZO BIOCHEM. INC'
Fecha ex-dividendo Dividendo por acción
15.11.2024 0,10 USD
29.06.1995 0,07 USD

Splits de acciones

Fecha Split
21.10.2004 105:100
26.06.2003 105:100
31.01.2002 105:100
23.02.2001 105:100
07.01.1998 105:100
04.10.1996 105:100
29.06.1995 105:100
30.06.1986 6:5
15.06.1983 3:2
13.04.1981 2:1
10.11.1980 2:1

Símbolos de cotización

Nombre Símbolo
Frankfurt EZB.F
NYSE ENZ

Otras acciones

Los inversores que tienen ENZO BIOCHEM. INC también tienen las siguientes acciones en su cartera:
FIN.RICHE. A ADR 1/10/SF1
FIN.RICHE. A ADR 1/10/SF1 Acción
SOC GENERALE UND.FLR 144A
SOC GENERALE UND.FLR 144A Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025